Ignyta and University of California, San Diego (UCSD) Researchers Find that Permanent Epigenetic Alterations are Associated with Immune Function in Rheumatoid Arthritis

Published: May 06, 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

SAN DIEGO--(BUSINESS WIRE)--Scientists from Ignyta, Inc., the personalized medicine company dedicated to improving the diagnosis and treatment of patients with rheumatoid arthritis, lupus and other autoimmune diseases, along with scientists from the University of California, San Diego School of Medicine, led by Gary S. Firestein, M.D., have published new findings about the immune function in rheumatoid arthritis. Their findings are published online in the April 2013 issue of the journal Genome Medicine (http://bit.ly/10tSY36).\

Help employers find you! Check out all the jobs and post your resume.

Back to news